Subscribe
Strategy
4 min

Mount Oak Launches Medtail Platform, Targets Vet Hospitals as Southeast Anchor Tenants

Mount Oak Capital launched a dedicated Medtail development platform and hired a former Truss Vet real estate lead to run it. The Charleston firm will target vet hospitals and adjacent medical tenants as anchors for purpose-built Southeast retail centers.

Written by
The Underbite
Published on
April 10, 2026
Mount Oak Launches Medtail Platform, Targets Vet Hospitals as Southeast Anchor Tenants

Charleston-based Mount Oak Capital has spun up a dedicated development vertical for medical-retail centers, hiring a former Truss Vet real estate lead to run it. For vet chain operators pushing into the Southeast, the launch signals a new source of purpose-built sites — and a landlord who understands how they underwrite leases.

What Happened

Mount Oak Capital, a Southeast-focused retail developer, announced a new Medtail platform on April 9 and named Adam Radcliffe Principal to lead it. Radcliffe previously served as Director of Real Estate at Truss Vet, a Cary, N.C.-based veterinary urgent care startup founded in 2021, where he oversaw clinic expansion across the Southeast.

The vertical will acquire sites in North Carolina, South Carolina, Georgia, Florida, Tennessee, and Virginia to build multi-tenant retail centers anchored by at least one medical-service tenant. Target anchors include veterinary hospitals, urgent care clinics, dental and orthodontic practices, physical therapy, dermatology, and med spas, paired with quick-service restaurants, fitness, and convenience retail.

Mount Oak said it has secured committed capital to fund a multi-project pipeline and move on site acquisitions, entitlements, and vertical construction on an accelerated timeline. The firm frames itself as the only vertically integrated retail developer with a dedicated Medtail vertical led by a former operator-side real estate head.

Why It Matters

Veterinary real estate has quietly become one of the tightest bottlenecks in the consolidation story. Private-equity-backed vet roll-ups and urgent care startups — Thrive, Bond Vet, Veterinary Emergency Group, Truss, Modern Animal — have spent the last several years competing for the same small pool of endcap and freestanding sites with drive access, parking, and neighborhood visibility. In the high-growth Southeast markets Mount Oak is targeting, competition for those boxes runs against dental, urgent care, and QSR tenants with similar site criteria and often deeper pockets.

A developer underwriting deals specifically around vet and adjacent medical anchors changes the math for operators in a few ways. It shortens the site-search cycle when a landlord is willing to build-to-suit against operator specs rather than retrofit existing boxes. It also pulls development risk off the operator's balance sheet, an attractive trade for chains still scaling on venture or PE capital who don't want to sit on land or carry construction delays.

Radcliffe's background is the relevant detail. Site selection, lease structuring, and ramp assumptions for vet clinics diverge meaningfully from general retail: utilities loads for surgery suites, waste handling, noise buffering, parking turnover tied to appointment cadence. A landlord who has modeled those variables from the tenant side is a different counterparty than one learning them in underwriting.

For existing operators, Mount Oak's platform is worth a phone call. For competitors eyeing the same Southeast corridors, it's a reminder that purpose-built medical retail is now a funded, staffed strategy rather than an opportunistic bet.

What to Watch

Whether Mount Oak names its committed capital partner. The release referenced a "dedicated source of capital" without specifying whether it's a single institutional LP, a programmatic JV, or a discretionary fund, each of which implies different deal velocity and hold periods.

Whether competing Southeast developers respond with similar verticals. Medtail as a thesis has been kicking around commercial real estate conferences for several years, but dedicated platforms with committed capital have been rare. If Mount Oak's pipeline fills quickly, expect regional competitors to stand up their own medical-anchored programs, and for vet chains to gain negotiating leverage as supply catches up.

And watch which vet operators sign the first leases. Mount Oak's credibility with the category will rise or fall on whether it lands a recognizable urgent care or specialty hospital brand on its first two or three projects.


This news brief is based on a company-submitted announcement. The Underbite verifies claims where possible but cannot independently confirm all details.

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

What's Happening

Other News

More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.

Read article
Vetspire Splits From Thrive, Lands a Battery Ventures Backing
Funding & M&A
4 min read

Vetspire Splits From Thrive, Lands a Battery Ventures Backing

Vetspire has spun out of Thrive Pet Healthcare's orbit with a growth investment from Battery Ventures and a new CEO, Zachary Seely. The AI-powered practice management platform, used by more than 800 veterinary hospitals and clinics, will operate independently while Thrive remains a customer. The deal tests whether AI-native vet software can draw institutional capital without a strategic parent underwriting it.

Read article
Read article
PetMeds Revenue Falls 20% as Takeover Fight Drags On
Earnings
6 min read

PetMeds Revenue Falls 20% as Takeover Fight Drags On

PetMeds' first-quarter revenue fell 19.9% to $41.0 million and cash reserves dropped to $13.1 million, even as the company narrowed its net loss to $6.1 million from $34.2 million a year earlier. The results land as an unsolicited $3-a-share buyout offer from SilverCape Investments remains on the table and a $37 million sale-leaseback of its headquarters awaits closing.

Read article
Read article
FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North
Regulatory
4 min read

FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North

The FDA granted Zoetis an emergency use authorization for Simparica Trio to treat New World screwworm in dogs, the first product cleared specifically for the threat. Texas has already begun requiring treatment before dogs cross certain lines, putting boarding facilities, transporters, and border-state vet practices under a new compliance mandate.

Read article
View all articles